Editor(s):

(1) Dr. Mohamed Salem Nasr Allah, Assistant Professor, Weill Cornell Medical College, Qatar.

Reviewers:

(1) R.Jaya Madhuri, Sri Padmavati Mahila Visvavidyalayam, India.

(2) Inés Llamas-Ramos, University of Salamanca, Spain.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6.25/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (R.Jaya Madhuri, India) | File 1 | File 2

Stage 2 | Peer review report_2 (Inés Llamas-Ramos, Spain) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems Propharmex Company, India.

(2) Dr. Aurora Martínez Romero, Professor and Researcher, Clinical Biochemistry, Juarez University, Durango, Mexico.

Reviewers:

(1) Manjula GB, King Khalid University, Saudi Arabia.

(2) Roghayeh khalilnezhad, Iran.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6.25/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Manjula GB, Saudi Arabia) | File 1 | NA

Stage 2 | Peer review report_2 (Roghayeh khalilnezhad, Iran) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Stage 3 | Comment_Editor_2_v1 | File 1 | NA

Editor(s): 

(1) Dr. Ana Cláudia Coelho, University of Trás-os–Montes and Alto Douro, Portugal.

Reviewers:

(1) Hitesh Katariya, Gujarat Technological University, India.

(2) Rashida Parveen, Superior University, Pakistan.

Additional Reviewers:

(1) Dharmik Mehta, R K University, India.

(2) Mahdi Jufri, Universitas Indonesia, Indonesia.

(3) Liyan Qiu, Zhejiang University, China.

(4) Pallavi M. Chaudhari, Dr. D. Y. Patil College of Pharmacy, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Hitesh Katariya, India) | File 1 | File 2

Stage 2 | Peer review report_2 (Rashida Parveen, Pakistan) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Giuseppe Murdaca, Clinical Immunology Unit, University of Genoa, Italy.

Reviewers:

(1) Dawosing Jayganesh, Mahatma Gandhi Institute, Mauritius.

(2) Promise Chika Oparah, Nnamdi Azkiwe University, Nigeria.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Dawosing Jayganesh, Mauritius) | File 1 | NA

Stage 2 | Peer review report_2 (Promise Chika Oparah, Nigeria) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems, Propharmex Company, India.

Reviewers:

(1) Rasha Hadi Saleh, University of Babylon, Iraq.

(2) Martha Orendu Oche Attah, Cyprus International University, Cyprus.

Additional Reviewers:

(1) Samith Ahmed, Trinity School of Medicine, West Indies.

(2) Eman  Ismail  Mohammed, Middle Technical University, Iraq.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6.5/10

Average Peer review marks at publication stage: 8.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Rasha Hadi Saleh, Iraq) | File 1 | File 2

Stage 2 | Peer review report_2 (Martha Orendu Oche Attah, Cyprus) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Paola Angelini, University of Perugia, Perugia, Italy.

Reviewers:

(1) Doaa Kamal Alkhalidi, Dubai Pharmacy College for Girls, UAE.

(2) Fatimah Jaffar AL-Hasani, University of technology, Iraq.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Doaa Kamal Alkhalidi, UAE) | File 1 | File 2

Stage 2 | Peer review report_2 (Fatimah Jaffar AL-Hasani, Iraq) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Aurora Martínez Romero, Professor and Researcher, Clinical Biochemistry, Juarez University,  Durango, Mexico.

Reviewers:

(1) S.Mothil, Kongu Engineering College, India.

(2) Asha Bhausaheb Kadam, Dada Patil Mahavidylaya Savitribai Phule Pune University, India.

(3) Kannan CS Warrier, Institute of Forest Genetics and Tree Breeding, Coimbatore, India.

Additional Reviewers:

(1) Kateryna Semchenko, National University of Pharmacy, Ukraine.

(2) Nikunj B. Patel, Sankalchand Patel University, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (S.Mothil, India) | File 1 | NA

Stage 2 | Peer review report_2 (Asha Bhausaheb Kadam, India) | File 1 | NA

Stage 2 | Peer review report_3 (Kannan CS Warrier, India) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Syed A. A. Rizvi, Nova Southeastern University, USA.

Reviewers:

(1) Jasobanta Sethi, Amity Institute of Physiotherapy Amity University, India.

(2) Poonam Chaturvedi, Lovely Professional University, India.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Jasobanta Sethi, India) | File 1 | NA

Stage 2 | Peer review report_2 (Poonam Chaturvedi, India) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Ana Cláudia Coelho, University of Trás-os–Montes and Alto Douro, Portugal.

Reviewers:

(1) Ritika Rocque, College of Nursing, All India Institute of Medical Sciences (AIIMS), India.

(2) R.Ponchitra, MGM Institute of Health sciences, India.

Additional Reviewers:

(1) Sumit Mukherjee, Anthropological Survey of India, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.75/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Ritika Rocque, India) | File 1 | NA

Stage 2 | Peer review report_2 (R.Ponchitra, India) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Giuseppe Murdaca, Clinical Immunology Unit, University of Genoa, Italy.

Reviewers:

(1) Bushra Fiza, Mahatma Gandhi University of Medical Sciences & Technology, India.

(2) K.Ravibabu, ICMR-Regional Occupational Health Centre(southern), India.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Bushra Fiza, India) | File 1 | NA

Stage 2 | Peer review report_2 (K.Ravibabu, India) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA